Effect of transcription-factor concentrations on leukemic stem cells

被引:88
作者
Rosenbauer, F [1 ]
Koschmieder, S [1 ]
Steidl, U [1 ]
Tenen, DG [1 ]
机构
[1] Harvard Univ, Sch Med, Inst Med, Boston, MA 02115 USA
关键词
D O I
10.1182/blood-2005-02-0717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increasing evidence suggests that leukemias are sustained by leukemic stem cells. However, the molecular pathways underlying the transformation of normal cells into leukemic stem cells are still poorly understood. The involvement of a small group of key transcription factors into this process was suggested by their frequent mutation or down-regulation in patients with acute myeloid leukemia (AML). Recent findings in mice with hypomorphic transcription-factor genes demonstrated that leukemic stem-cell formation in AML could directly be caused by reduced transcription-factor activity beyond a critical threshold. Most interestingly, those experimental models and the paucity of biallelic null mutations or deletions in transcription-factor genes in patients suggest that AML is generally associated with graded down-regulation rather than complete disruption of transcription factors. Here, we discuss the effects of transcription-factor concentrations on hematopoiesis and leukemia, with a focus on the regulation of transcription-factor gene expression as a major mechanism that alters critical threshold levels during blood development and cancer.
引用
收藏
页码:1519 / 1524
页数:6
相关论文
共 76 条
[1]   A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]   ALTERNATIVE TRANSLATION INITIATION SITE USAGE RESULTS IN 2 FUNCTIONALLY DISTINCT FORMS OF THE GATA-1 TRANSCRIPTION FACTOR [J].
CALLIGARIS, R ;
BOTTARDI, S ;
COGOI, S ;
APEZTEGUIA, I ;
SANTORO, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11598-11602
[4]   Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias [J].
Cilloni, D ;
Carturan, S ;
Gottardi, E ;
Messa, F ;
Messa, E ;
Fava, M ;
Diverio, D ;
Guerrasio, A ;
Lo-Coco, F ;
Saglio, G .
BLOOD, 2003, 102 (07) :2705-2706
[5]   PU. 1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain [J].
Cook, WD ;
McCaw, BJ ;
Herring, C ;
John, DL ;
Foote, SJ ;
Nutt, SL ;
Adams, JM .
BLOOD, 2004, 104 (12) :3437-3444
[6]   Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors [J].
Cozzio, A ;
Passegué, E ;
Ayton, PM ;
Karsunky, H ;
Cleary, ML ;
Weissman, IL .
GENES & DEVELOPMENT, 2003, 17 (24) :3029-3035
[7]   Spi-B can functionally replace PU.1 in myeloid but not lymphoid development [J].
Dahl, R ;
Ramirez-Bergeron, DL ;
Rao, S ;
Simon, MC .
EMBO JOURNAL, 2002, 21 (09) :2220-2230
[8]   Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBP ratio and granulocyte colony-stimulating factor [J].
Dahl, R ;
Walsh, JC ;
Lancki, D ;
Laslo, P ;
Iyer, SR ;
Singh, H ;
Simon, MC .
NATURE IMMUNOLOGY, 2003, 4 (10) :1029-1036
[9]   PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis [J].
Dakic, A ;
Metcalf, D ;
Di Rago, L ;
Mifsud, S ;
Wu, L ;
Nutt, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1487-1502
[10]   Regulation of B lymphocyte and macrophage development by graded expression of PU.1 [J].
DeKoter, RP ;
Singh, H .
SCIENCE, 2000, 288 (5470) :1439-1441